Literature DB >> 7572297

Depression during hormonal treatment of prostate cancer.

D E Rosenblatt1, A Mellow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7572297

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


× No keyword cloud information.
  8 in total

1.  Adverse events associated with hormonal therapy for prostate cancer.

Authors:  Ravi J Kumar; Al Barqawi; E David Crawford
Journal:  Rev Urol       Date:  2005

Review 2.  A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants.

Authors:  Lene Thorsen; Kerry S Courneya; Clare Stevinson; Sophie D Fosså
Journal:  Support Care Cancer       Date:  2008-02-15       Impact factor: 3.603

3.  An exploratory study of the factors that influence physical activity for prostate cancer survivors.

Authors:  Melinda J Craike; Patricia M Livingston; Mari Botti
Journal:  Support Care Cancer       Date:  2010-07-10       Impact factor: 3.603

4.  Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.

Authors:  Morgan Lee; Heather S Jim; Mayer Fishman; Babu Zachariah; Randy Heysek; Matthew Biagioli; Paul B Jacobsen
Journal:  Psychooncology       Date:  2014-06-13       Impact factor: 3.894

5.  Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer.

Authors:  Vahakn B Shahinian; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal:  Arch Intern Med       Date:  2006-02-27

Review 6.  Health-related quality-of-life assessments in patients with advanced cancer of the prostate.

Authors:  Jan Adolfsson
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

7.  Prospective study of depression and fatigue in men with advanced prostate cancer receiving hormone therapy.

Authors:  William F Pirl; Joseph A Greer; Melissa Goode; Matthew R Smith
Journal:  Psychooncology       Date:  2008-02       Impact factor: 3.894

8.  Changes in Beck Depression Inventory scores in prostate cancer patients undergoing androgen deprivation therapy or prostatectomy.

Authors:  Dongseong Shin; Sung Ryul Shim; Chang Hee Kim
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.